A 61-year-old female patient with treatment-resistant, end-stage mantle cell lymphoma and progressive central nervous system involvement with diffuse leptomeningeal lymphomatosis presented with sudden vision loss in the right eye for 2 weeks. On examination, visual acuity was no light perception OD. Fundus examination revealed severe, infiltrative optic neuropathy; ophthalmic artery occlusion with a cherry-red spot and macular edema; central retinal vein occlusion with dilated, cyanotic retinal veins and retinal hemorrhages in 4 quadrants; and preretinal, neoplastic vitreous seeding layering on a subhyaloid, preretinal, boat-shaped hemorrhage (Figure). Mantle cell lymphoma has a high recurrence rate and poor prognosis, with median survival ranging from 3 to 5 years from presentation.1 The ocular adnexal manifestations of mantle cell lymphoma have been described, but intraocular involvement is exceedingly rare.2 The patient’s retinal vascular compression resulted from an infiltrative neoplastic mass effect. Unfortunately, the patient died 3 weeks after presentation.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Corresponding Author: Timothy W. Olsen, MD, Department of Ophthalmology, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (email@example.com).
Conflict of Interest Disclosures: None reported.
Additional Contributions: We thank the patient’s family for granting permission to publish this information.
Credit Designation Statement: The American Medical Association designates this Journal-based CME activity activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.
You currently have no searches saved.
You currently have no courses saved.